Top
NTNG1 has not been detected as a mutational cancer driver

NTNG1
Ensembl id ENSG00000162631
Mutated samples
Coding Sequence 89 (1.3%)
Protein Affecting 60 (0.9%)
Mode of action Unclassified
Known driver No
Cancer type Signals (Biases)
Clust Clustered Mutations FM Functional Mutations Rec Recurrent Mutations
This plot shows the most recurrently mutated cancer types in all NTNG1 gene mutations. Each bar of the histogram indicates the amount of samples with PAMs.

Cancer type Driver Mutated samples (CS) Mutated samples (PAM) % Mutated samples (PAM)
Cutaneous melanoma No 22 15 4.07
Lung adenocarcinoma No 12 11 2.81
Breast carcinoma No 6 4 0.35
Prostate adenocarcinoma No 3 3 1.23
Bladder carcinoma No 4 3 3.06
Uterine corpus endometrioid carcinoma No 4 3 1.30
Serous ovarian adenocarcinoma No 3 3 0.95
Stomach adenocarcinoma No 5 3 1.86
Small cell lung carcinoma No 3 3 4.35
Colorectal adenocarcinoma No 2 2 0.87
Medulloblastoma No 1 1 0.48
Lung squamous cell carcinoma No 1 1 0.57
Pancreas adenocarcinoma No 1 1 0.47
Renal clear cell carcinoma No 1 1 0.24
Neuroblastoma No 1 1 0.48
Non small cell lung carcinoma No 1 1 3.23
Lower grade glioma No 1 1 0.59
Head and neck squamous cell carcinoma No 3 1 0.27
Glioblastoma multiforme No 1 1 0.26
Esophageal carcinoma No 7 1 0.68
Hepatocarcinoma No 3 0 0.00
Chronic lymphocytic leukemia No 3 0 0.00
Pylocytic astrocytoma No 1 0 0.00
The mutations needle plot shows the distribution of the observed cancer mutations along the protein sequence and it's possible mutational clusters and hotspots. The needles' height and head size represent mutational recurrence. Needles of different categories that fall in the same amino acid residues are stacked.

Variant Locus Samples AA pos AA change Consequence